Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ZFGN

Zafgen (ZFGN) Stock Price, News & Analysis

Zafgen logo

About Zafgen Stock (NASDAQ:ZFGN)

Key Stats

Today's Range
$4.13
$4.29
50-Day Range
$0.99
$25.06
52-Week Range
$0.62
$2.76
Volume
861,025 shs
Average Volume
360,199 shs
Market Capitalization
$160.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZFGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zafgen and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZFGN Stock News Headlines

Tokyo Steel Manufacturing Co Ltd 5423
Arizona-made nanochips the new millionaire maker?
George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the last 40 years. Now he's stepping forward with an even bigger prediction about what's being built in the Arizona desert. He believes 3 little-known companies will explode when a bombshell announcement just days from now. Smart investors are already positioning themselves.tc pixel
Food and drink in a castle
LRMR Larimar Therapeutics, Inc.
Form 424B5 Larimar Therapeutics, - StreetInsider.com
See More Headlines

ZFGN Stock Analysis - Frequently Asked Questions

Zafgen Inc (NASDAQ:ZFGN) announced its earnings results on Thursday, March, 5th. The biopharmaceutical company reported ($0.19) EPS for the quarter, hitting the consensus estimate of ($0.19).

Based on aggregate information from My MarketBeat watchlists, some other companies that Zafgen investors own include Xtrackers California Municipal Bond ETF (CA), Bristol Myers Squibb (BMY), Endologix (ELGX), Energy Transfer (ET), BlackRock (BLK), TG Therapeutics (TGTX) and SCYNEXIS (SCYX).

Company Calendar

Last Earnings
3/05/2020
Today
9/19/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ZFGN
CIK
1374690
Fax
N/A
Employees
38
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$45.41 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-51.34%
Return on Assets
-34.55%

Debt

Debt-to-Equity Ratio
0.26
Current Ratio
6.56
Quick Ratio
6.56

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.35 per share
Price / Book
3.17

Miscellaneous

Outstanding Shares
37,470,000
Free Float
N/A
Market Cap
$160.37 million
Optionable
Not Optionable
Beta
0.27
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:ZFGN) was last updated on 9/19/2025 by MarketBeat.com Staff
From Our Partners